Lung cancer is the foremost cause of cancer-related deaths world-wide [1]. It affects 100,000 Americans of the smoking population every year of all age groups, particularly those above 50 years of the smoking population [2]. In India, 51,000 lung cancer deaths were reported in 2012, which include 41,000 men and 10,000 women [3]. It is the leading cause of cancer deaths in men; however, in women, it ranked ninth among all cancerous
deaths [4]. It is possible to detect the lung cancer at a very early stage, providing a much higher chance of survival for the patients.
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment